Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:18434325rdf:typepubmed:Citationlld:pubmed
pubmed-article:18434325lifeskim:mentionsumls-concept:C0384648lld:lifeskim
pubmed-article:18434325lifeskim:mentionsumls-concept:C1704675lld:lifeskim
pubmed-article:18434325lifeskim:mentionsumls-concept:C1416467lld:lifeskim
pubmed-article:18434325lifeskim:mentionsumls-concept:C1825592lld:lifeskim
pubmed-article:18434325lifeskim:mentionsumls-concept:C1705947lld:lifeskim
pubmed-article:18434325lifeskim:mentionsumls-concept:C0439851lld:lifeskim
pubmed-article:18434325lifeskim:mentionsumls-concept:C1158816lld:lifeskim
pubmed-article:18434325lifeskim:mentionsumls-concept:C1552596lld:lifeskim
pubmed-article:18434325lifeskim:mentionsumls-concept:C1947931lld:lifeskim
pubmed-article:18434325lifeskim:mentionsumls-concept:C2717992lld:lifeskim
pubmed-article:18434325pubmed:issue25lld:pubmed
pubmed-article:18434325pubmed:dateCreated2008-6-16lld:pubmed
pubmed-article:18434325pubmed:abstractTextThe cytokine, transforming growth factor-beta1 (TGF-beta1), converts naive T cells into regulatory T cells that prevent autoimmunity. However, in the presence of interleukin (IL)-6, TGF-beta1 has also been found to promote differentiation into IL-17-producing helper T (Th17) cells that are deeply involved in autoimmunity and inflammation. However, it has not been clarified how TGF-beta1 and IL-6 determine such a distinct fate. Here we found that a master regulator for Th17, retinoic acid-related orphan receptor gammat (RORgammat), was rapidly induced by TGF-beta1 regardless of the presence of IL-6. IL-6 reduced Foxp3 expression, and overexpression of Foxp3 in a T cell line resulted in a strong reduction of IL-17A expression. We have characterized the IL-17A promoter and found that RORgammat binding is sufficient for activation of the minimum promoter in the HEK 293T cells. RORgammat-mediated IL-17A promoter activation was suppressed by forced expression of Foxp3. Foxp3 directly interacted with RORgammat through exon 2 region of Foxp3. The exon 2 region and forkhead (FKH) domain of Foxp3 were necessary for the suppression of RORgammat-mediated IL-17A promoter activation. We propose that induction of Foxp3 is the mechanism for the suppression of Th17 and polarization into inducible Treg.lld:pubmed
pubmed-article:18434325pubmed:languageenglld:pubmed
pubmed-article:18434325pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18434325pubmed:citationSubsetIMlld:pubmed
pubmed-article:18434325pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18434325pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18434325pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18434325pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18434325pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18434325pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18434325pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18434325pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18434325pubmed:statusMEDLINElld:pubmed
pubmed-article:18434325pubmed:monthJunlld:pubmed
pubmed-article:18434325pubmed:issn0021-9258lld:pubmed
pubmed-article:18434325pubmed:authorpubmed-author:KobayashiTaka...lld:pubmed
pubmed-article:18434325pubmed:authorpubmed-author:TakaesuGiichi...lld:pubmed
pubmed-article:18434325pubmed:authorpubmed-author:YoshidaHideyu...lld:pubmed
pubmed-article:18434325pubmed:authorpubmed-author:YoshimuraAkih...lld:pubmed
pubmed-article:18434325pubmed:authorpubmed-author:HoriShoheiSlld:pubmed
pubmed-article:18434325pubmed:authorpubmed-author:ChinenTakatos...lld:pubmed
pubmed-article:18434325pubmed:authorpubmed-author:SaekiKazukoKlld:pubmed
pubmed-article:18434325pubmed:authorpubmed-author:NakayaMakoMlld:pubmed
pubmed-article:18434325pubmed:authorpubmed-author:IchiyamaKenji...lld:pubmed
pubmed-article:18434325pubmed:authorpubmed-author:WakabayashiYu...lld:pubmed
pubmed-article:18434325pubmed:issnTypePrintlld:pubmed
pubmed-article:18434325pubmed:day20lld:pubmed
pubmed-article:18434325pubmed:volume283lld:pubmed
pubmed-article:18434325pubmed:ownerNLMlld:pubmed
pubmed-article:18434325pubmed:authorsCompleteYlld:pubmed
pubmed-article:18434325pubmed:pagination17003-8lld:pubmed
pubmed-article:18434325pubmed:dateRevised2009-11-19lld:pubmed
pubmed-article:18434325pubmed:meshHeadingpubmed-meshheading:18434325...lld:pubmed
pubmed-article:18434325pubmed:meshHeadingpubmed-meshheading:18434325...lld:pubmed
pubmed-article:18434325pubmed:meshHeadingpubmed-meshheading:18434325...lld:pubmed
pubmed-article:18434325pubmed:meshHeadingpubmed-meshheading:18434325...lld:pubmed
pubmed-article:18434325pubmed:meshHeadingpubmed-meshheading:18434325...lld:pubmed
pubmed-article:18434325pubmed:meshHeadingpubmed-meshheading:18434325...lld:pubmed
pubmed-article:18434325pubmed:meshHeadingpubmed-meshheading:18434325...lld:pubmed
pubmed-article:18434325pubmed:meshHeadingpubmed-meshheading:18434325...lld:pubmed
pubmed-article:18434325pubmed:meshHeadingpubmed-meshheading:18434325...lld:pubmed
pubmed-article:18434325pubmed:meshHeadingpubmed-meshheading:18434325...lld:pubmed
pubmed-article:18434325pubmed:meshHeadingpubmed-meshheading:18434325...lld:pubmed
pubmed-article:18434325pubmed:meshHeadingpubmed-meshheading:18434325...lld:pubmed
pubmed-article:18434325pubmed:meshHeadingpubmed-meshheading:18434325...lld:pubmed
pubmed-article:18434325pubmed:meshHeadingpubmed-meshheading:18434325...lld:pubmed
pubmed-article:18434325pubmed:meshHeadingpubmed-meshheading:18434325...lld:pubmed
pubmed-article:18434325pubmed:meshHeadingpubmed-meshheading:18434325...lld:pubmed
pubmed-article:18434325pubmed:meshHeadingpubmed-meshheading:18434325...lld:pubmed
pubmed-article:18434325pubmed:year2008lld:pubmed
pubmed-article:18434325pubmed:articleTitleFoxp3 inhibits RORgammat-mediated IL-17A mRNA transcription through direct interaction with RORgammat.lld:pubmed
pubmed-article:18434325pubmed:affiliationDivision of Molecular and Cellular Immunology, Medical Institute of Bioregulation, Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka 812-8582, Japan.lld:pubmed
pubmed-article:18434325pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:18434325pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
entrez-gene:3605entrezgene:pubmedpubmed-article:18434325lld:entrezgene
entrez-gene:6097entrezgene:pubmedpubmed-article:18434325lld:entrezgene
entrez-gene:50943entrezgene:pubmedpubmed-article:18434325lld:entrezgene
entrez-gene:16171entrezgene:pubmedpubmed-article:18434325lld:entrezgene
entrez-gene:19885entrezgene:pubmedpubmed-article:18434325lld:entrezgene
entrez-gene:20371entrezgene:pubmedpubmed-article:18434325lld:entrezgene
http://linkedlifedata.com/r...entrezgene:pubmedpubmed-article:18434325lld:entrezgene
http://linkedlifedata.com/r...entrezgene:pubmedpubmed-article:18434325lld:entrezgene
http://linkedlifedata.com/r...entrezgene:pubmedpubmed-article:18434325lld:entrezgene
http://linkedlifedata.com/r...entrezgene:pubmedpubmed-article:18434325lld:entrezgene
http://linkedlifedata.com/r...entrezgene:pubmedpubmed-article:18434325lld:entrezgene
http://linkedlifedata.com/r...entrezgene:pubmedpubmed-article:18434325lld:entrezgene
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:18434325lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:18434325lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:18434325lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:18434325lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:18434325lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:18434325lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:18434325lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:18434325lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:18434325lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:18434325lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:18434325lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:18434325lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:18434325lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:18434325lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:18434325lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:18434325lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:18434325lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:18434325lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:18434325lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:18434325lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:18434325lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:18434325lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:18434325lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:18434325lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:18434325lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:18434325lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:18434325lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:18434325lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:18434325lld:pubmed
More...